Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Raw Materials: 2023-2024

Historic Raw Materials for Harmony Biosciences Holdings (HRMY) over the last 1 years, with Dec 2024 value amounting to $944,000.

  • Harmony Biosciences Holdings' Raw Materials fell 10.94% to $944,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $944,000, marking a year-over-year decrease of 10.94%. This contributed to the annual value of $944,000 for FY2024, which is 10.94% down from last year.
  • Harmony Biosciences Holdings' Raw Materials amounted to $944,000 in Q4 2024, which was down 8.62% from $1.0 million recorded in Q3 2024.
  • Harmony Biosciences Holdings' 5-year Raw Materials high stood at $1.1 million for Q2 2024, and its period low was $944,000 during Q4 2024.
  • Its 2-year average for Raw Materials is $1.0 million, with a median of $1.0 million in 2024.
  • Data for Harmony Biosciences Holdings' Raw Materials shows a maximum YoY dropped of 10.94% (in 2024) over the last 5 years.
  • Harmony Biosciences Holdings' Raw Materials (Quarterly) stood at $1.1 million in 2023, then fell by 10.94% to $944,000 in 2024.
  • Its last three reported values are $944,000 in Q4 2024, $1.0 million for Q3 2024, and $1.1 million during Q2 2024.